Billings Clinic
Especially For:

Clinical Trials

Title   Crohns
Description   A phase 3 randomized, double-blind, placebo controlled, multicenter, parallel group study to assess the efficacy and safety of fixed-dose combination RHB-104 in subjects with moderately to severely active Crohn's disease.
IRB Number   RHB-104-01
Category   Gastrointestinal
Inclusion/Notes   You may qualifity to participate if:

* Age 18 to 65
* Crohns disease diagnosed by endoscopy or radiography at least 6 months prior to study enrollment

Qualified participants may receive study medicatin, study related medical care, and payment for completed visits
Status   Currently Enrolling
Start Date   09/29/2013
Principal Investigator (PI)   Steven Hammond, MD
Contact Name   Recruitment Hotline
Contact Email   Research Department
Phone   (406) 657-4111
Alternate Phone   (800) 996-2663
Fax   (406) 435-8479
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.